IBDEI07L ; ; 06-AUG-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;AUG 06, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10002,1,1,0)
 ;;=1^283.9
 ;;^UTILITY(U,$J,358.3,10002,1,8,0)
 ;;=8^Hemolytic Anemia,Acquired
 ;;^UTILITY(U,$J,358.3,10002,2)
 ;;=^7071
 ;;^UTILITY(U,$J,358.3,10003,0)
 ;;=283.0^^68^585^11
 ;;^UTILITY(U,$J,358.3,10003,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,10003,1,1,0)
 ;;=1^283.0
 ;;^UTILITY(U,$J,358.3,10003,1,8,0)
 ;;=8^Hemolytic Anemia,Autoimmun
 ;;^UTILITY(U,$J,358.3,10003,2)
 ;;=^7079
 ;;^UTILITY(U,$J,358.3,10004,0)
 ;;=283.19^^68^585^13
 ;;^UTILITY(U,$J,358.3,10004,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,10004,1,1,0)
 ;;=1^283.19
 ;;^UTILITY(U,$J,358.3,10004,1,8,0)
 ;;=8^Hemolytic Anemia,Microangiopathic
 ;;^UTILITY(U,$J,358.3,10004,2)
 ;;=^293664
 ;;^UTILITY(U,$J,358.3,10005,0)
 ;;=280.9^^68^585^14
 ;;^UTILITY(U,$J,358.3,10005,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,10005,1,1,0)
 ;;=1^280.9
 ;;^UTILITY(U,$J,358.3,10005,1,8,0)
 ;;=8^Iron Defic Anemia
 ;;^UTILITY(U,$J,358.3,10005,2)
 ;;=^276946
 ;;^UTILITY(U,$J,358.3,10006,0)
 ;;=281.0^^68^585^17
 ;;^UTILITY(U,$J,358.3,10006,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,10006,1,1,0)
 ;;=1^281.0
 ;;^UTILITY(U,$J,358.3,10006,1,8,0)
 ;;=8^Pernicious Anemia
 ;;^UTILITY(U,$J,358.3,10006,2)
 ;;=^7161
 ;;^UTILITY(U,$J,358.3,10007,0)
 ;;=285.9^^68^585^20
 ;;^UTILITY(U,$J,358.3,10007,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,10007,1,1,0)
 ;;=1^285.9
 ;;^UTILITY(U,$J,358.3,10007,1,8,0)
 ;;=8^Unspecified Anemia
 ;;^UTILITY(U,$J,358.3,10007,2)
 ;;=^7007
 ;;^UTILITY(U,$J,358.3,10008,0)
 ;;=281.8^^68^585^16
 ;;^UTILITY(U,$J,358.3,10008,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,10008,1,1,0)
 ;;=1^281.8
 ;;^UTILITY(U,$J,358.3,10008,1,8,0)
 ;;=8^Nutritional Anemia
 ;;^UTILITY(U,$J,358.3,10008,2)
 ;;=^267979
 ;;^UTILITY(U,$J,358.3,10009,0)
 ;;=285.21^^68^585^2
 ;;^UTILITY(U,$J,358.3,10009,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,10009,1,1,0)
 ;;=1^285.21
 ;;^UTILITY(U,$J,358.3,10009,1,8,0)
 ;;=8^Anemia End-Stage Renal Disease
 ;;^UTILITY(U,$J,358.3,10009,2)
 ;;=^321977
 ;;^UTILITY(U,$J,358.3,10010,0)
 ;;=285.22^^68^585^3
 ;;^UTILITY(U,$J,358.3,10010,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,10010,1,1,0)
 ;;=1^285.22
 ;;^UTILITY(U,$J,358.3,10010,1,8,0)
 ;;=8^Anemia In Neoplastic Disease
 ;;^UTILITY(U,$J,358.3,10010,2)
 ;;=^321978
 ;;^UTILITY(U,$J,358.3,10011,0)
 ;;=285.29^^68^585^4
 ;;^UTILITY(U,$J,358.3,10011,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,10011,1,1,0)
 ;;=1^285.29
 ;;^UTILITY(U,$J,358.3,10011,1,8,0)
 ;;=8^Anemia Oth Chronic Illness
 ;;^UTILITY(U,$J,358.3,10011,2)
 ;;=^321979
 ;;^UTILITY(U,$J,358.3,10012,0)
 ;;=285.1^^68^585^1
 ;;^UTILITY(U,$J,358.3,10012,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,10012,1,1,0)
 ;;=1^285.1
 ;;^UTILITY(U,$J,358.3,10012,1,8,0)
 ;;=8^Ac Posthemorrhag Anemia
 ;;^UTILITY(U,$J,358.3,10012,2)
 ;;=^267986
 ;;^UTILITY(U,$J,358.3,10013,0)
 ;;=284.2^^68^585^15
 ;;^UTILITY(U,$J,358.3,10013,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,10013,1,1,0)
 ;;=1^284.2
 ;;^UTILITY(U,$J,358.3,10013,1,8,0)
 ;;=8^Myelophthisic Anemia
 ;;^UTILITY(U,$J,358.3,10013,2)
 ;;=^334037
 ;;^UTILITY(U,$J,358.3,10014,0)
 ;;=281.9^^68^585^8
 ;;^UTILITY(U,$J,358.3,10014,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,10014,1,1,0)
 ;;=1^281.9
 ;;^UTILITY(U,$J,358.3,10014,1,8,0)
 ;;=8^Deficiency Anemia
 ;;^UTILITY(U,$J,358.3,10014,2)
 ;;=^123801
 ;;^UTILITY(U,$J,358.3,10015,0)
 ;;=284.89^^68^585^5
 ;;^UTILITY(U,$J,358.3,10015,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,10015,1,1,0)
 ;;=1^284.89
 ;;^UTILITY(U,$J,358.3,10015,1,8,0)
 ;;=8^Anemia d/t CA or Drugs
 ;;^UTILITY(U,$J,358.3,10015,2)
 ;;=^87880
 ;;^UTILITY(U,$J,358.3,10016,0)
 ;;=281.1^^68^585^7
 ;;^UTILITY(U,$J,358.3,10016,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,10016,1,1,0)
 ;;=1^281.1
 ;;^UTILITY(U,$J,358.3,10016,1,8,0)
 ;;=8^B12 Defic Anemia NEC
 ;;^UTILITY(U,$J,358.3,10016,2)
 ;;=^267974
 ;;^UTILITY(U,$J,358.3,10017,0)
 ;;=281.2^^68^585^9
 ;;^UTILITY(U,$J,358.3,10017,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,10017,1,1,0)
 ;;=1^281.2
 ;;^UTILITY(U,$J,358.3,10017,1,8,0)
 ;;=8^Folate-Def Anemia
 ;;^UTILITY(U,$J,358.3,10017,2)
 ;;=^259686
 ;;^UTILITY(U,$J,358.3,10018,0)
 ;;=282.60^^68^585^18
 ;;^UTILITY(U,$J,358.3,10018,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,10018,1,1,0)
 ;;=1^282.60
 ;;^UTILITY(U,$J,358.3,10018,1,8,0)
 ;;=8^Sickle Cell Anemia NOS
 ;;^UTILITY(U,$J,358.3,10018,2)
 ;;=^330077
 ;;^UTILITY(U,$J,358.3,10019,0)
 ;;=285.0^^68^585^19
 ;;^UTILITY(U,$J,358.3,10019,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,10019,1,1,0)
 ;;=1^285.0
 ;;^UTILITY(U,$J,358.3,10019,1,8,0)
 ;;=8^Sideroblastic Anemia
 ;;^UTILITY(U,$J,358.3,10019,2)
 ;;=^7204
 ;;^UTILITY(U,$J,358.3,10020,0)
 ;;=286.9^^68^586^2
 ;;^UTILITY(U,$J,358.3,10020,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,10020,1,1,0)
 ;;=1^286.9
 ;;^UTILITY(U,$J,358.3,10020,1,8,0)
 ;;=8^Defective Coagulation,Unspec
 ;;^UTILITY(U,$J,358.3,10020,2)
 ;;=^87267
 ;;^UTILITY(U,$J,358.3,10021,0)
 ;;=446.6^^68^586^9
 ;;^UTILITY(U,$J,358.3,10021,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,10021,1,1,0)
 ;;=1^446.6
 ;;^UTILITY(U,$J,358.3,10021,1,8,0)
 ;;=8^Thrombotic Thrombocytopenic Purpura (TTP)
 ;;^UTILITY(U,$J,358.3,10021,2)
 ;;=^119061
 ;;^UTILITY(U,$J,358.3,10022,0)
 ;;=451.9^^68^586^8
 ;;^UTILITY(U,$J,358.3,10022,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,10022,1,1,0)
 ;;=1^451.9
 ;;^UTILITY(U,$J,358.3,10022,1,8,0)
 ;;=8^Thrombophlebitis
 ;;^UTILITY(U,$J,358.3,10022,2)
 ;;=^93357
 ;;^UTILITY(U,$J,358.3,10023,0)
 ;;=287.5^^68^586^6
 ;;^UTILITY(U,$J,358.3,10023,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,10023,1,1,0)
 ;;=1^287.5
 ;;^UTILITY(U,$J,358.3,10023,1,8,0)
 ;;=8^Thrombocytopenia Nos
 ;;^UTILITY(U,$J,358.3,10023,2)
 ;;=^118988
 ;;^UTILITY(U,$J,358.3,10024,0)
 ;;=287.1^^68^586^5
 ;;^UTILITY(U,$J,358.3,10024,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,10024,1,1,0)
 ;;=1^287.1
 ;;^UTILITY(U,$J,358.3,10024,1,8,0)
 ;;=8^Qualitative Platelet Defects
 ;;^UTILITY(U,$J,358.3,10024,2)
 ;;=^101922
 ;;^UTILITY(U,$J,358.3,10025,0)
 ;;=287.30^^68^586^4
 ;;^UTILITY(U,$J,358.3,10025,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,10025,1,1,0)
 ;;=1^287.30
 ;;^UTILITY(U,$J,358.3,10025,1,8,0)
 ;;=8^Primary Thrombocytopenia (ITP)
 ;;^UTILITY(U,$J,358.3,10025,2)
 ;;=^332841
 ;;^UTILITY(U,$J,358.3,10026,0)
 ;;=238.71^^68^586^7
 ;;^UTILITY(U,$J,358.3,10026,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,10026,1,1,0)
 ;;=1^238.71
 ;;^UTILITY(U,$J,358.3,10026,1,8,0)
 ;;=8^Thrombocytosis,Essential
 ;;^UTILITY(U,$J,358.3,10026,2)
 ;;=^334027
 ;;^UTILITY(U,$J,358.3,10027,0)
 ;;=286.0^^68^586^1
 ;;^UTILITY(U,$J,358.3,10027,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,10027,1,1,0)
 ;;=1^286.0
 ;;^UTILITY(U,$J,358.3,10027,1,8,0)
 ;;=8^Congenital Factor VIII
 ;;^UTILITY(U,$J,358.3,10027,2)
 ;;=^27454
 ;;^UTILITY(U,$J,358.3,10028,0)
 ;;=275.03^^68^586^3
 ;;^UTILITY(U,$J,358.3,10028,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,10028,1,1,0)
 ;;=1^275.03
 ;;^UTILITY(U,$J,358.3,10028,1,8,0)
 ;;=8^Hemochromatosis NEC
 ;;^UTILITY(U,$J,358.3,10028,2)
 ;;=^339604
 ;;^UTILITY(U,$J,358.3,10029,0)
 ;;=205.00^^68^587^1
 ;;^UTILITY(U,$J,358.3,10029,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,10029,1,1,0)
 ;;=1^205.00
 ;;^UTILITY(U,$J,358.3,10029,1,8,0)
 ;;=8^A M L, W/O Remission
 ;;^UTILITY(U,$J,358.3,10029,2)
 ;;=^267531
 ;;^UTILITY(U,$J,358.3,10030,0)
 ;;=205.01^^68^587^2
 ;;^UTILITY(U,$J,358.3,10030,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,10030,1,1,0)
 ;;=1^205.01
 ;;^UTILITY(U,$J,358.3,10030,1,8,0)
 ;;=8^A M L,In Remission
 ;;^UTILITY(U,$J,358.3,10030,2)
 ;;=^267532
 ;;^UTILITY(U,$J,358.3,10031,0)
 ;;=205.10^^68^587^4
 ;;^UTILITY(U,$J,358.3,10031,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,10031,1,1,0)
 ;;=1^205.10
 ;;^UTILITY(U,$J,358.3,10031,1,8,0)
 ;;=8^C M L,W/O Remission
 ;;^UTILITY(U,$J,358.3,10031,2)
 ;;=^267533
 ;;^UTILITY(U,$J,358.3,10032,0)
 ;;=205.11^^68^587^3
 ;;^UTILITY(U,$J,358.3,10032,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,10032,1,1,0)
 ;;=1^205.11
 ;;^UTILITY(U,$J,358.3,10032,1,8,0)
 ;;=8^C M L,In Remission
 ;;^UTILITY(U,$J,358.3,10032,2)
 ;;=^267534
 ;;^UTILITY(U,$J,358.3,10033,0)
 ;;=289.0^^68^587^7
 ;;^UTILITY(U,$J,358.3,10033,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,10033,1,1,0)
 ;;=1^289.0
 ;;^UTILITY(U,$J,358.3,10033,1,8,0)
 ;;=8^Secondary Polycythemia
 ;;^UTILITY(U,$J,358.3,10033,2)
 ;;=^186856
 ;;^UTILITY(U,$J,358.3,10034,0)
 ;;=238.4^^68^587^6
 ;;^UTILITY(U,$J,358.3,10034,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,10034,1,1,0)
 ;;=1^238.4
 ;;^UTILITY(U,$J,358.3,10034,1,8,0)
 ;;=8^Polycythemia Rubra Vera
 ;;^UTILITY(U,$J,358.3,10034,2)
 ;;=^96105
 ;;^UTILITY(U,$J,358.3,10035,0)
 ;;=288.9^^68^587^9
 ;;^UTILITY(U,$J,358.3,10035,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,10035,1,1,0)
 ;;=1^288.9
 ;;^UTILITY(U,$J,358.3,10035,1,8,0)
 ;;=8^Unspecified Dis Of W B C
 ;;^UTILITY(U,$J,358.3,10035,2)
 ;;=^267993
 ;;^UTILITY(U,$J,358.3,10036,0)
 ;;=289.81^^68^587^8
 ;;^UTILITY(U,$J,358.3,10036,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,10036,1,1,0)
 ;;=1^289.81
 ;;^UTILITY(U,$J,358.3,10036,1,8,0)
 ;;=8^Unspecified Blood Diseases
 ;;^UTILITY(U,$J,358.3,10036,2)
 ;;=^329886
 ;;^UTILITY(U,$J,358.3,10037,0)
 ;;=238.75^^68^587^5
 ;;^UTILITY(U,$J,358.3,10037,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,10037,1,1,0)
 ;;=1^238.75
 ;;^UTILITY(U,$J,358.3,10037,1,8,0)
 ;;=8^Myelodysplastic Syndrome
 ;;^UTILITY(U,$J,358.3,10037,2)
 ;;=^334031
 ;;^UTILITY(U,$J,358.3,10038,0)
 ;;=204.00^^68^588^2
 ;;^UTILITY(U,$J,358.3,10038,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,10038,1,1,0)
 ;;=1^204.00
 ;;^UTILITY(U,$J,358.3,10038,1,8,0)
 ;;=8^A L L,W/O Remission
 ;;^UTILITY(U,$J,358.3,10038,2)
 ;;=^267521
 ;;^UTILITY(U,$J,358.3,10039,0)
 ;;=204.01^^68^588^1
 ;;^UTILITY(U,$J,358.3,10039,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,10039,1,1,0)
 ;;=1^204.01
 ;;^UTILITY(U,$J,358.3,10039,1,8,0)
 ;;=8^A L L, In Remission
